| P50 | author | Pablo Moscato | Q48588595 |
| | Elena Prieto | Q57451771 |
| | Luke Mathieson | Q59697406 |
| P2093 | author name string | Drew Mellor | |
| P2860 | cites work | The NCI60 human tumour cell line anticancer drug screen | Q29614975 |
| | Optimal drug combinations and minimal hitting sets | Q33491286 |
| | DNA fingerprinting of the NCI-60 cell line panel | Q33608214 |
| | North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer | Q33618149 |
| | Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base | Q33934669 |
| | Docetaxel: a review of its use in metastatic breast cancer | Q34468674 |
| | Learning rule-based models of biological process from gene expression time profiles using gene ontology. | Q38522764 |
| | Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: results of a Radiation Therapy Oncology Group pilot study | Q39537227 |
| | MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? | Q39834203 |
| | AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in precl | Q40093939 |
| | Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor | Q40164535 |
| | Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial | Q43250043 |
| | Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthra | Q43290572 |
| | Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in HeLa cells. | Q45909763 |
| | FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG). | Q45918152 |
| | Small, fuzzy and interpretable gene expression based classifiers | Q48502411 |
| | Computing knock-out strategies in metabolic networks. | Q51622450 |
| | Nonseminomatous malignant germ cell tumors in children. Multidrug therapy in stages III and IV | Q72392769 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e13055 | |
| P577 | publication date | 2010-10-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A kernelisation approach for multiple d-Hitting Set and its application in optimal multi-drug therapeutic combinations | |
| P478 | volume | 5 | |